002382 藍帆醫療
按盤價 
5.680 +0.160 (+2.899%)
5.680 +0.160 (+2.899%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 4,181,729 | -10.15% | 6,253,168 | 4,927,075 | 4,900,478 | 8,108,586 | |
| 減：營業總成本 | 4,540,280 | -6.69% | 6,620,497 | 5,560,762 | 5,524,116 | 5,727,872 | |
| 其中:營業成本 | 3,610,324 | -6.35% | 5,222,702 | 4,320,997 | 4,398,973 | 4,301,551 | |
| 財務費用 | 139,786 | -15.50% | 199,256 | 124,258 | 33,873 | 167,490 | |
| 資產減值損失 | (45,174) | 194.37% | (53,736) | (72,256) | (82,338) | (2,117,249) | |
| 公允價值變動收益 | 6,606 | -103,196.09% | 6,542 | 70,628 | (6,742) | 1,098,472 | |
| 投資收益 | 13,482 | -274.60% | (7,474) | 14,408 | 257,712 | 24,309 | |
| 其中：對聯營企業和合營企業的投資收益 | 7,253 | -189.03% | (8,132) | 4,438 | (24,104) | 2,527 | |
| 營業利潤 | (345,908) | 51.34% | (416,564) | (604,846) | (402,079) | 1,390,548 | |
| 利潤總額 | (347,690) | 62.23% | (401,604) | (622,610) | (405,860) | 1,347,358 | |
| 減：所得稅費用 | (44,994) | -457.04% | 63,317 | (54,250) | (33,544) | 191,649 | |
| 淨利潤 | (302,696) | 33.39% | (464,921) | (568,360) | (372,316) | 1,155,709 | |
| 減：非控股權益 | (16,734) | 135.66% | (19,312) | -- | 0 | (1) | |
| 股東淨利潤 | (285,962) | 30.09% | (445,609) | (568,360) | (372,316) | 1,155,709 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.280 | 27.27% | -0.440 | -0.560 | -0.370 | 1.130 | |
| 每股派息 (元) * | -- | -- | -- | -- | 0.400 | -- | |
| 每股淨資產 (元) * | 7.650 | -10.90% | 7.941 | 9.294 | 10.290 | -- | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 19/12/2025 15:03 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
